Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Ashley R AlbrightDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA 94158.ORCID 0000-0002-7163-9640
Connie YanDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA 94158.ORCID 0000-0002-9961-0671
David Angeles-AlboresThe Organogenesis and Tissue Replacement Lab, San Francisco, CA 94107.
Yina HudnallDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA 94158.ORCID 0009-0006-3543-0029
Tatyana MakushokDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA 94158.
Jamarc Allen-HendersonDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA 94158.
Wallace F MarshallDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA 94158.ORCID 0000-0002-8467-5763
Funding
UCSF IRACDA Scholars ProgramK12GM081266 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Raymond M. Esquerra, HOLLY A. INGRAHAM · 2007 to 2026
$19.4M
Origins of Cell GeometryR35GM130327 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Wallace Marshall · 2019 to 2026
$5.3M
Illumina NovaSeq 6000 Sequencing SystemS10OD028511 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHOW, ERIC D · 2020 to 2020
$583k
Supplement For Continuity Through Major Life EventK99GM154059 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Ashley R Albright · 2024 to 2026
$291k
HHS | NIH | National Institute of General Medical Sciences (NIGMS) 5K12GM081266HHS | NIH | National Institute of General Medical Sciences (NIGMS) K99GM154059NIGMS NIH HHS K12 GM081266NIGMS NIH HHS K99 GM154059NIGMS NIH HHS R35 GM130327NIH HHS S10 OD028511
6 · The paper itself
Abstract
The molecular mechanisms that produce cell structure are poorly understood. The giant ciliate
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Genome-wide analysis of mRNA regionalization in a giant single cell. · full record | OpenQuestion